• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Diamedica Therapeutics Inc (NQ: DMAC )

    4.550 +0.260 (+6.06%)
    Streaming Delayed Price Updated: 11:48 AM EDT, Sep 13, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Diamedica Therapeutics Inc

    < Previous 1 2 3 4 5 Next >
    Mid-Morning Market Update: Markets Mostly Higher; FactSet Research Reports Mixed Q3 Results
    Following the market opening Tuesday, the Dow traded up 0.40% to 34,420.32 while the NASDAQ fell 0.10% to 14,486.23. The S&P also rose, gaining 0.14% to 4,296.59. The U.S. has... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    DiaMedica Therapeutics Stock Slips On Mixed DM199 Data In Chronic Kidney Disease Patients
    DiaMedica Therapeutics Inc (NASDAQ: DMAC) has announced positive interim results from its Phase 2 REDUX trial of DM199 in chronic kidney disease (CKD). The... 
    Via Benzinga
    The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28) Alexion Pharmaceuticals,... 
    Via Benzinga
    Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
    Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
    Via Benzinga
    Exposures Product Safety
    DiaMedica Therapeutics Announces Positive Interim Results from Phase 2 REDUX Study in CKD
    From DiaMedica Therapeutics Inc.
    Via Business Wire
    DiaMedica Stock Gains On Green Signal To Start Pivotal DM199 Trial In Ischemic Stroke
    The FDA has signed off DiaMedica Therapeutics Inc's (NASDAQ: DMAC) Investigational New Drug (IND) application to proceed with a pivotal Phase 2/3 study of... 
    Via Benzinga
    Exposures Product Safety
    DiaMedica Therapeutics Announces FDA Clearance of IND Application to Initiate Phase 2/3 Clinical Trial for DM199 for Acute Ischemic Stroke
    From DiaMedica Therapeutics Inc.
    Via Business Wire
    DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2021 Financial Results
    From DiaMedica Therapeutics Inc.
    Via Business Wire
    The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... 
    Via Benzinga
    DiaMedica Therapeutics to Report First Quarter 2021 Financials and Provide a Business Update May 6, 2021
    From DiaMedica Therapeutics Inc.
    Via Business Wire
    DiaMedica Therapeutics to Participate in the B. Riley Securities’ Neuroscience Conference
    From DiaMedica Therapeutics Inc.
    Via Business Wire
    38 Stocks Moving In Friday's Mid-Day Session
    Gainers Celcuity Inc. (NASDAQ: CELC) shares jumped 64.5% to $23.54 after the company announced a worldwide licensing agreement with Pfizer to develop and commercialize... 
    Via Benzinga
    51 Biggest Movers From Friday
    Gainers Celcuity Inc. (NASDAQ: CELC) shares climbed 50.9% to close at $21.60 on Friday after the company announced a worldwide licensing agreement with Pfizer to develop and... 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Gainers Greenwich LifeSciences (NASDAQ:GLSI) stock moved upwards by 32.67% to $67.0 during Friday's pre-market session. The company's market cap stands at $860.7... 
    Via Benzinga
    30 Stocks Moving in Friday's Pre-Market Session
    Gainers Celcuity Inc. (NASDAQ: CELC) rose 32.3% to $19.00 in pre-market trading after the company reported a worldwide licensing agreement with Pfizer to develop and... 
    Via Benzinga
    10 Stocks Moving In Thursday's After-Hours Session
    Gainers FuboTV (NYSE: FUBO) shares are trading higher after the company announced it acquired exclusive streaming rights to the Qatar World Cup 2022 Qualifying matches of South... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Gainers DiaMedica Therapeutics (NASDAQ:DMAC) shares increased by 6.17% to $9.98 during Thursday's after-market session. DiaMedica Therapeutics's trading volume hit 12.0K... 
    Via Benzinga
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.